Humira for Psoriasis
Links shared publicly online about this topic
Humira Replaces Enbrel As The Therapy Perceived By Dermatologists To Be The Most Efficacious For The Treatment Of Moderate To Severe Psoriasis
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most effic” View full resource at medicalnewstoday.com
Most Recently Shared on April 1, 2010 at 11:37 am By:
Humira Replaces Enbrel As The Therapy Perceived By Dermatologists To Be The Most Efficacious For The Treatment Of Mod.. http://bit.ly/aMuS6H
Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey
news-medical.net — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe psoriasis, the highest proportion of surveyed dermatologists and managed care organizations' (MCOs) pharmacy directors indicate that Abbott/Eisai's Humira and Amgen/Pfizer/Stiefel/Takeda's Enbrel have the best overall clinical profile when compared to other currently available agents.” View full resource at news-medical.net
Most Recently Shared on February 9, 2011 at 3:22 pm By:
Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey: Deci... http://bit.ly/ieEoBf
Briakinumab: psoriasis blockbuster coming? | Psoriasis Cure Now!
psoriasis-cure-now.org — “Briakinumab, an experimental psoriasis treatment from Abbott (the folks who bring us Humira ), continues to rack up favorable results in clinical trials. Most” View full resource at psoriasis-cure-now.org
Most Recently Shared on July 16, 2010 at 2:05 am By:
Psoriasis Cure Now Health Organization
Briakinumab--a coming blockbuster for psoriasis? http://www.psoriasis-cure-now.org/2010/07/16/briakinumab-psoriasis-blockbuster-coming
For the Treatment of Moderate to Severe Psoriasis, the Highest Proportion of Surveyed Dermatologists and MCOs Indicate That Humira and Enbrel Have the Best Overall Clinical Profile When Compared to Other Currently Available Agents | Business Wire
businesswire.com — “Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatme” View full resource at businesswire.com
Most Recently Shared on February 7, 2011 at 9:16 pm By:
For the Treatment of Moderate to Severe Psoriasis, the Highest Proportion of Surveyed Dermatologists and MCOs In... http://bit.ly/fgMTjb
Medical News: TNF Inhibitor Reduces Arthritis Pain in Psoriasis - in Dermatology, Psoriasis from MedPage Today
medpagetoday.com — “The tumor necrosis factor inhibitor adalimumab (Humira) reduced pain and the risk of adverse events in patients with psoriatic arthritis, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2010 at 2:43 pm By:
PsoriasisTx.com Dermatology and Health Site
TNF Inhibitor Reduces Arthritis Pain in Psoriasis - in Dermatology, Psoriasis from MedPage Today: http://bit.ly/didPIx via @addthis
Medical News: Psoriasis Drug Efficacy Decreases as Antibodies Rise - in Dermatology, Psoriasis from MedPage Today
medpagetoday.com — “Some psoriasis patients who take adalimumab (Humira) for treatment of plaque psoriasis become unresponsive to the drug over time, a new Dutch study found.” View full resource at medpagetoday.com
Most Recently Shared on February 22, 2010 at 10:09 pm By:
PsoriasisTx.com Dermatology and Health Site
Psoriasis Drug Efficacy Decreases as Antibodies Rise - in Dermatology, Psoriasis from MedPage Today: http://bit.ly/cZYFQG via @addthis
Columnists | New drugs available for resistant psoriasis | The Detroit News
detnews.com — “Dear Dr. Donohue: I was first diagnosed with psoriasis in July 1972, at the age of 23. I am now 63. I am in my 40th year of suffering from this dreadful disease. I have tried virtually every form of treatment. I have studied the new biological treatments now available, and it is with a certain amount of trepidation that I am considering trying Humira, recommended by my wife's ob-gyn, who also has the disease and took this treatment.” View full resource at detnews.com
Most Recently Shared on October 10, 2011 at 10:20 am By:
Dr. Paul Donohue: New drugs available for resistant psoriasis: Dear Dr. Donohue: I was first diagnosed with psor... http://t.co/N0Mww53I
Medical News: AAD: Anti-TNF Therapy Improves Psoriasis and Psoriatic Arthritis - in Meeting Coverage, AAD from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Patients with psoriasis and concomitant psoriatic arthritis got relief from both conditions when treated with the monoclonal antibody adalimumab (Humira), according to pooled data fro” View full resource at medpagetoday.com
Most Recently Shared on March 26, 2009 at 10:10 pm By:
National Psoriasis Foundation Dermatology and Health Organization
AAD: Anti-TNF Therapy Improves Psoriasis and Psoriatic Arthritis http://tinyurl.com/c8ojvk
Medical News: AAD: Restarting Anti-TNF Agent Works in Relapsed Psoriasis - in Meeting Coverage, AAD from MedPage Today
medpagetoday.com — “MIAMI BEACH -- A majority of patients with relapsed psoriasis regained control of the disease when retreated with the tumor necrosis factor (TNF) inhibitor adalimumab (Humira), results of a small clin” View full resource at medpagetoday.com
Most Recently Shared on March 15, 2010 at 5:22 pm By:
National Psoriasis Foundation Dermatology and Health Organization
Restarting Anti-TNF agent works in relapsed psoriasis. http://fb.me/6oAXNYb
Medical News: AAD: Restarting Anti-TNF Agent Works in Relapsed Psoriasis - in Meeting Coverage, AAD from MedPage Today
medpagetoday.com — “MIAMI BEACH -- A majority of patients with relapsed psoriasis regained control of the disease when retreated with the tumor necrosis factor (TNF) inhibitor adalimumab (Humira), results of a small clin” View full resource at medpagetoday.com
Most Recently Shared on March 21, 2010 at 4:13 pm By:
PsoriasisTx.com Dermatology and Health Site
Restarting Anti-TNF Agent Works in Relapsed Psoriasis - in Meeting Coverage, AAD from MedPage Today: http://bit.ly/cyFueG via @addthis
FDA warns Abbott over ad for psoriasis drug - MarketWatch
marketwatch.com — “WASHINGTON (MarketWatch) -- Federal regulators warned Abbott Laboratories over an advertisement for the company's psoriasis drug Humira, saying it is misleading and makes claims not supported by scientific evidence. The ad for Humira suggests the drug is approved for any patient with moderate to severe chronic plaque psoriasis, even though the product is only approved for a more limited patient population, the Food and Drug Administration said in a Dec.” View full resource at marketwatch.com
Most Recently Shared on December 26, 2008 at 11:37 pm By:
National Psoriasis Foundation Dermatology and Health Organization
FDA warns Abbott over ad for psoriasis drug http://tinyurl.com/8hbhnk
Donohue: New and powerful drugs available for resistant psoriasis | The Town Talk | thetowntalk.com
thetowntalk.com — “Dear Dr. Donohue: I was first diagnosed with psoriasis in July 1972, at the age of 23. I am now 63. I begin my 40th year of suffering from this dreadful disease. I have tried virtually every form of treatment. I have studied the new biological treatments now available, and it is with a certain amount of trepidation that I am considering trying Humira, recommended by my wife's ob-gyn, who also has the disease and took this treatment. Could you shed some light on this subject? I am leaning toward ” View full resource at thetowntalk.com
Most Recently Shared on October 10, 2011 at 12:53 pm By:
Donohue: New and powerful drugs available for resistant psoriasis: Dear Dr. Donohue: I was first diagnosed with ... http://t.co/d3wn5zwH
FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009
drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009” View full resource at drugs.com
Most Recently Shared on August 31, 2009 at 8:40 pm By:
FDA Alert - Update: FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/SB68Y
FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)
drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)” View full resource at drugs.com
Most Recently Shared on August 5, 2009 at 1:04 am By:
FDA Alert - FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/xqXMR
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
medical_tweets
-
Psoriasis OW
Organizing psoriasis resources shared by health experts, advocates, and organizations into WisdomCards.
-
Psoriasis Cure Now
Nonprofit org for psoriasis and psoriatic arthritis patients. We block those promoting phony treatments/cures. www.psoriasis-cure-now.org and www.Psoriasis.Name
Advertisement
